Showing results (21-30 of 79) with videos related to
Sort By:
Pageof 8
Biochemical Pharmacology|November 26, 2003
Glycyrrhetinic acid-induced permeability transition in rat liver mitochondriaMauro Salvi, Cristina Fiore, Decio Armanini, et al.Biochimica Et Biophysica Acta|December 4, 2002
Interaction of genistein with the mitochondrial electron transport chain results in opening of the membrane transition poreMauro Salvi, Anna Maria Brunati, Giulio Clari, et al.International Journal of Molecular Sciences|September 9, 2022
KDM2A and KDM3B as Potential Targets for the Rescue of F508del-CFTRClaudio D'Amore, Christian Borgo, Valentina Bosello Travain, et al.Cell Death Discovery|October 30, 2021
Targeting CK2 in cancer: a valuable strategy or a waste of time?Mauro Salvi, Christian Borgo, Lorenzo A Pinna, et al.Biochimica Et Biophysica Acta|April 18, 2015
Proteomics perturbations promoted by the protein kinase CK2 inhibitor quinalizarinCinzia Franchin, Mauro Salvi, Giorgio Arrigoni, et al.Journal of Proteome Research|May 11, 2010
Motif analysis of phosphosites discloses a potential prominent role of the Golgi casein kinase (GCK) in the generation of human plasma phospho-proteomeMauro Salvi, Luca Cesaro, Elena Tibaldi, et al.The FEBS Journal|February 26, 2017
Fam20C is under the control of sphingolipid signaling in human cell linesGiorgio Cozza, Mauro Salvi, Vincent S Tagliabracci, et al.Signal Transduction and Targeted Therapy|May 17, 2021
Protein kinase CK2: a potential therapeutic target for diverse human diseasesChristian Borgo, Claudio D'Amore, Stefania Sarno, et al.FEBS Letters|November 14, 2007
Identification of the flavoprotein of succinate dehydrogenase and aconitase as in vitro mitochondrial substrates of Fgr tyrosine kinaseMauro Salvi, Nick A Morrice, Anna Maria Brunati, et al.Plos One|October 23, 2014
Identification of the PLK2-dependent phosphopeptidome by quantitative proteomics [corrected]Cinzia Franchin, Luca Cesaro, Lorenzo A Pinna, et al.Pageof 8